Osaic Holdings
MRKR icon

Osaic Holdings’s Marker Therapeutics MRKR Stock Holding History

Osaic Holdings’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Buy
112,649
+19,528
+21% +$28.5K ﹤0.01% 4575
2026
Q1 		$121K Sell
93,121
-1,300
-1% -$2.06K ﹤0.01% 4538
2025
Q4 		$141K Buy
94,421
+13,340
+16% +$15.1K ﹤0.01% 4428
2025
Q3 		$74.2K Buy
81,081
+61,504
+314% +$75.9K ﹤0.01% 5030
2025
Q2 		$30K Buy
19,577
+1,630
+9% +$2.09K ﹤0.01% 5408
2025
Q1 		$22.1K Buy
17,947
+9,412
+110% +$17.2K ﹤0.01% 5289
2024
Q4 		$26.5K Buy
8,535
+1,450
+20% +$5.13K ﹤0.01% 5139
2024
Q3 		$20K Hold
7,085
– – ﹤0.01% 5387
2024
Q2 		$38.5K Sell
7,085
-1,500
-17% -$6.37K ﹤0.01% 4881
2024
Q1 		$36.9K Buy
8,585
+2,200
+34% +$9.61K ﹤0.01% 4949
2023
Q4 		$35.1K Sell
6,385
-4,027
-39% -$13.6K ﹤0.01% 5129
2023
Q3 		$47.3K Buy
10,412
+5,965
+134% +$33.3K ﹤0.01% 5040
2023
Q2 		$13.8K Sell
4,447
-3,018
-40% -$5.25K ﹤0.01% 5794
2023
Q1 		$5.3K Buy
7,465
+66
+0.9% +$157 ﹤0.01% 6299
2022
Q4 		$20.6K Buy
7,399
+2,778
+60% +$9.58K ﹤0.01% 5552
2022
Q3 		$17K Sell
4,621
-200
-4% -$734 ﹤0.01% 5709
2022
Q2 		$16K Sell
4,821
-100
-2% -$333 ﹤0.01% 5771
2022
Q1 		$22K Buy
4,921
+929
+23% +$5.31K ﹤0.01% 5630
2021
Q4 		$38K Sell
3,992
-479
-11% -$6.36K ﹤0.01% 5349
2021
Q3 		$76K Sell
4,471
-690
-13% -$14.1K ﹤0.01% 4769
2021
Q2 		$144K Buy
5,161
+3,195
+163% +$84.1K ﹤0.01% 4168
2021
Q1 		$44K Buy
+1,966
New +$45K ﹤0.01% 4970

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Osaic Holdings's MRKR Position: Q2 2026 in Review

Osaic Holdings increased its Marker Therapeutics (MRKR) stake by 21% in Q2 2026, buying an estimated $28.5K and bringing the position to 112,649 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #4575.

Osaic Holdings first reported a position in MRKR in Q1 2021 and has held it in 22 quarters since. 35 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

  • Osaic Holdings held 112,649 shares of Marker Therapeutics worth $166K as of Q2 2026.
  • Osaic Holdings bought 19,528 Marker Therapeutics shares in Q2 2026, an estimated $28.5K.
  • Marker Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4575 holding.
  • Osaic Holdings first reported a position in Marker Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • 35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.